Study: My Understanding of Options

Some Things that You Should Know Regarding Bipolar Depression

You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Children and adults are affected by this condition. This is one fact that you must understand. Women would suffer the most from this kind of depression that is called bipolar depression disorder.

It is not strange in any case since even if women suffer from such regular bipolar kind of depression or a depressive disorder, they would spend more time depressed than they do being manic. This isn’t to say that only the women are depressive, the men also are and they may get affected by such condition.

The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.

Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.

Such bipolar affective disorder is another name for the bipolar disorder or such manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.

The monotherapy trials from placebo is actually the gold-standard design in knowing the efficacy when it comes to the treatment of bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. The switch to mania or such hypomania can be a consequence of the active treatment for such bipolar depression.

Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Thus, the 12-week trials against placebo are needed to determine the risk of switch and establish the continuing effects. You have to know that such careful assessment at six to eight weeks are needed to guarantee that the patients who fail to respond won’t continue in the study for such unacceptable periods of time.